Last reviewed · How we verify
NCT04984200
Assessment of EyeArt Performance With Retinal Cameras
trial testing Retinal imaging in Diabetic Retinopathy in 246 participants. Completed in 19 August 2022.
19 August 2022
Quick facts
| Lead sponsor | Eyenuk, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 246 |
| Start date | 13 July 2021 |
| Primary completion | 19 August 2022 |
| Estimated completion | 19 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Retinal imaging
- Mydriatic Agent — full drug profile →
Conditions studied
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Sponsor
Eyenuk, Inc. — full company profile →
Who can join
22 and older, any sex, with Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using retinal cameras and operators.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04984200
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Retinal imaging
Trials testing the same drug.
- NCT06541834 — Predicting the Risk of Diabetic Neurodegenerative Disorders by Artificial Intelligence Tools Based on Retinal Imaging · recruiting
- NCT05655793 — The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis · unknown
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
- NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes · NA · recruiting
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
- NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting
Other Eyenuk, Inc. trials
Trials by the same sponsor.
- NCT04302012 — Assessment of EyeArt Performance With Retinal Imaging Devices · completed
- NCT03112005 — Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool · completed
- NCT03078231 — Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04984200 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eyenuk, Inc.
- Last refreshed: 9 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04984200.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing